This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Facchini PJ, De Luca V. Opium poppy and Madagascar periwinkle: Model non-model systems to investigate alkaloid biosynthesis in plants. Plant J. 2008; 54(4): 763-784.FacchiniPJDe LucaV.Opium poppy and Madagascar periwinkle: Model non-model systems to investigate alkaloid biosynthesis in plantsPlant J200854476378410.1111/j.1365-313X.2008.03438.xSearch in Google Scholar
Moudi MR, Go R, Yien CY, Nazre M. Vinca alkaloids. Int J Prev Med. 2013; 4(11): 1231-1235.MoudiMRGoRYienCYNazreM.Vinca alkaloidsInt J Prev Med201341112311235Search in Google Scholar
Duffin J. Poisoning the spindle: Serendipity and discovery of the anti-tumor properties of the Vinca alkaloids. Pharm Hist. 2002; 44(2?): 64-76.DuffinJ.Poisoning the spindle: Serendipity and discovery of the anti-tumor properties of the Vinca alkaloidsPharm Hist2002442?647610.3138/cbmh.17.1.155Search in Google Scholar
Ribatti D, Guidolin D, Conconi MT, Nico B, Baiguera S, Parnigotto PP, et al. Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo. Oncogene. 2003; 22(41): 6458-6461.RibattiDGuidolinDConconiMTNicoBBaigueraSParnigottoPPet al.Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivoOncogene200322416458646110.1038/sj.onc.1206789Search in Google Scholar
Toussaint C, Izzo J, Spielmann M, Merle S, May-Levin F, Armand JP, et al. Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer. J Clin Oncol. 1994; 12(10): 2102-2112.ToussaintCIzzoJSpielmannMMerleSMay-LevinFArmandJPet al.Phase I/II trial of continuous infusion vinorelbine for advanced breast cancerJ Clin Oncol199412102102211210.1200/JCO.1994.12.10.2102Search in Google Scholar
Freyer G, Delozier T, Lichinister M, Gedouin D, Bougnoux P, His P, et al. Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy. J Clin Oncol. 2003; 21(1): 35-40.FreyerGDelozierTLichinisterMGedouinDBougnouxPHisPet al.Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapyJ Clin Oncol20032113540Search in Google Scholar
Rusthoven J, Bramwell V, Stephenson B. Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site Group. Cancer Prev Control. 1998; 2(4): 179-190.RusthovenJBramwellVStephensonB.Use of granulocyte colony-stimulating factor (G-CSF) in patients receiving myelosuppressive chemotherapy for the treatment of cancer. Provincial Systemic Treatment Disease Site GroupCancer Prev Control199824179190Search in Google Scholar
Hirano M, Okamoto M, Maruyama F, Ezaki K, Shimizu K, Ino T, et al. Alternating non-crossresistant chemotherapy for non-Hodgkin’s lymphoma of inter-mediate-grade and high-grade malignancy. A pilot study. Cancer. 1992; 69(3): 772-777.HiranoMOkamotoMMaruyamaFEzakiKShimizuKInoTet al.Alternating non-crossresistant chemotherapy for non-Hodgkin’s lymphoma of inter-mediate-grade and high-grade malignancy. A pilot studyCancer199269377277710.1002/1097-0142(19920201)69:3<772::AID-CNCR2820690326>3.0.CO;2-ZSearch in Google Scholar
Coderch C, Morreale A, Gago F. Tubulin-based structure-affinity relationships for antimitotic Vinca alkaloids. Anticancer Agents Med Chem. 2012; 12(3): 219-225.CoderchCMorrealeAGagoF.Tubulin-based structure-affinity relationships for antimitotic Vinca alkaloidsAnticancer Agents Med Chem201212321922510.2174/187152012800228841Search in Google Scholar
Jiang W, Lu Y, Chen Z, Chen S, Zhang M, Jin L, et al. Studying the genotoxicity of vincristine on human lymphocytes using comet assay, micronucleus assay and TCR gene mutation test in vitro. Toxicology. 2008; 252(1-3): 113-117.JiangWLuYChenZChenSZhangMJinLet al.Studying the genotoxicity of vincristine on human lymphocytes using comet assay, micronucleus assay and TCR gene mutation test in vitroToxicology20082521-311311710.1016/j.tox.2008.07.057Search in Google Scholar
Choudhury RC, Palo AK, Padhy A. Cytogenetic consequences of vinblastine treatment in mouse bone marrow. Chemotherapy. 2004; 50(4): 171-177.ChoudhuryRCPaloAKPadhyA.Cytogenetic consequences of vinblastine treatment in mouse bone marrowChemotherapy200450417117710.1159/000080690Search in Google Scholar
Morales-Ramirez P, Vallarino-Kelly T, Cruz-Vallejo V. Kinetics of micronucleus induction and cytotoxicity caused by distinct antineoplastics and alkylating agents in vivo. Toxicol Lett. 2014; 224(3): 319-325.Morales-RamirezPVallarino-KellyTCruz-VallejoV.Kinetics of micronucleus induction and cytotoxicity caused by distinct antineoplastics and alkylating agents in vivoToxicol Lett2014224331932510.1016/j.toxlet.2013.11.012Search in Google Scholar
Morales-Ramirez P, Vallarino-Kelly T, Cruz-Vallejo V. Kinetics of micronucleated polychromatic erythrocyte (MN-PCE) induction in vivo by aneuploidogens. Mutat Res. 2004; 565(1): 79-87.Morales-RamirezPVallarino-KellyTCruz-VallejoV.Kinetics of micronucleated polychromatic erythrocyte (MN-PCE) induction in vivo by aneuploidogensMutat Res20045651798710.1016/j.mrgentox.2004.09.006Search in Google Scholar
Yamada T, Odawara K, Kaneko H. Concurrent detection of gene mutations and chromosome aberrations induced by five chemicals in a CHL/IU cell line incorporating a gpt shuttle vector. Mutat Res. 2000; 471(1-2): 29-36.YamadaTOdawaraKKanekoH.Concurrent detection of gene mutations and chromosome aberrations induced by five chemicals in a CHL/IU cell line incorporating a gpt shuttle vectorMutat Res20004711-2293610.1016/S1383-5718(00)00115-7Search in Google Scholar
Arni P, Hertner T. Chromosomal aberrations in vitro induced by aneugens. Mutat Res. 1997; 379(1): 83-93.ArniPHertnerT.Chromosomal aberrations in vitro induced by aneugensMutat Res19973791839310.1016/S0027-5107(97)00111-5Search in Google Scholar
Gonzalez-Cid M, Larripa I, Slavutsky I. Vinorelbine: Cell cycle kinetics and differential sensitivity of human lymphocyte subpopulations. Toxicol Lett. 1997; 93(2-3): 171-176.Gonzalez-CidMLarripaISlavutskyI.Vinorelbine: Cell cycle kinetics and differential sensitivity of human lymphocyte subpopulationsToxicol Lett1997932-317117610.1016/S0378-4274(97)00089-1Search in Google Scholar
Tiburi M, Reguly ML, Schwartsmann G, Cunha KS, Lehmann M, Rodrigues de Andrade HH. Comparative genotoxic effect of vincristine, vinblastine, and vinorelbine in somatic cells of Drosophila melanogaster. Mutat Res. 2002; 519(1-2): 141-149.TiburiMRegulyMLSchwartsmannGCunhaKSLehmannMRodrigues de AndradeHH.Comparative genotoxic effect of vincristine, vinblastine, and vinorelbine in somatic cells of Drosophila melanogasterMutat Res20025191-214114910.1016/S1383-5718(02)00136-5Search in Google Scholar
Gundy S, Baki M, Bodrogi I. Vinblastine, cisplatin and bleomycin (VPB) adjuvant therapy does not induce dose-dependent damage in human chromosomes. Neoplasma. 1989; 36(4): 457-464.GundySBakiMBodrogiI.Vinblastine, cisplatin and bleomycin (VPB) adjuvant therapy does not induce dose-dependent damage in human chromosomesNeoplasma1989364457464Search in Google Scholar
Morgan WF, Crossen PE. A comparison of induced sister chromatid exchange levels in Chinese hamster ovary cells and cultured human lymphocytes. Environ Mutagen. 1982; 4(1): 65-71.MorganWFCrossenPE.A comparison of induced sister chromatid exchange levels in Chinese hamster ovary cells and cultured human lymphocytesEnviron Mutagen198241657110.1002/em.28600401096175512Search in Google Scholar
Gonzalez-Cid M, Cuello MT, Larripa I. Mitotic arrest and anaphase aberrations induced by vinorelbine in hamster cells in vitro. Anticancer Drugs. 1997; 8(5): 529-532.Gonzalez-CidMCuelloMTLarripaI.Mitotic arrest and anaphase aberrations induced by vinorelbine in hamster cells in vitroAnticancer Drugs19978552953210.1097/00001813-199706000-000179215618Search in Google Scholar
Alzoubi K, Khabour O, Khader M, Mhaidat N, Al-Azzam S. Evaluation of vitamin B12 effects on DNA damage induced by paclitaxel. Drug Chem Toxicol. 2014; 37(3): 276-280.AlzoubiKKhabourOKhaderMMhaidatNAl-AzzamS.Evaluation of vitamin B12 effects on DNA damage induced by paclitaxelDrug Chem Toxicol201437327628010.3109/01480545.2013.85168624215581Search in Google Scholar
Alzoubi K, Khabour O, Hussain N, Al-Azzam S, Mhaidat M. Evaluation of vitamin B12 effects on DNA damage induced by pioglitazone. Mutat Res. 2012; 748(1-2): 48-51.AlzoubiKKhabourOHussainNAl-AzzamSMhaidatM.Evaluation of vitamin B12 effects on DNA damage induced by pioglitazoneMutat Res20127481-2485110.1016/j.mrgentox.2012.06.00922790087Search in Google Scholar
Alsatari ES, Azab M, Khabour OF, Alzoubi KH, Sadiq MF. Assessment of DNA damage using chromosomal aberrations assay in lymphocytes of waterpipe smokers. Int J Occup Med Environ Health. 2012; 25(3): 218-224.AlsatariESAzabMKhabourOFAlzoubiKHSadiqMF.Assessment of DNA damage using chromosomal aberrations assay in lymphocytes of waterpipe smokersInt J Occup Med Environ Health201225321822410.2478/s13382-012-0027-5372422222729491Search in Google Scholar
Khabour OF, Alsatari ES, Azab M, Alzoubi KH, Sadiq MF. Assessment of genotoxicity of waterpipe and cigarette smoking in lymphocytes using the sister-chromatid exchange assay: A comparative study. Environ Mol Mutagen. 2011; 52(3): 224-228.KhabourOFAlsatariESAzabMAlzoubiKHSadiqMF.Assessment of genotoxicity of waterpipe and cigarette smoking in lymphocytes using the sister-chromatid exchange assay: A comparative studyEnviron Mol Mutagen201152322422810.1002/em.2060120740646Search in Google Scholar
Alzoubi KH, Khabour OF, Jaber AG, Al-Azzam SI, Mhaidat NM, Masadeh MM. Tempol prevents geno-toxicity induced by vorinostat: role of oxidative DNA damage. Cytotechnology. 2014; 66(3): 449-455.AlzoubiKHKhabourOFJaberAGAl-AzzamSIMhaidatNMMasadehMM.Tempol prevents geno-toxicity induced by vorinostat: role of oxidative DNA damageCytotechnology201466344945510.1007/s10616-013-9597-8Search in Google Scholar
Khabour OF, Alzoubi KH, Mfady DS, Alasseiri M, Hasheesh TF. Tempol protects human lymphocytes from genotoxicity induced by cisplatin. Int J Clin Exp Med. 2014; 7(4): 982-988.KhabourOFAlzoubiKHMfadyDSAlasseiriMHasheeshTF.Tempol protects human lymphocytes from genotoxicity induced by cisplatinInt J Clin Exp Med201474982988Search in Google Scholar
Al-Sweedan SA, Khabour O, Isam R. Genotoxicity assessment in patients with thalassemia minor. Mutat Res. 2012; 744(2): 167-171.Al-SweedanSAKhabourOIsamR.Genotoxicity assessment in patients with thalassemia minorMutat Res2012744216717110.1016/j.mrgentox.2012.02.010Search in Google Scholar
Kaya FF, Topaktas M. Genotoxic effects of potassium bromate on human peripheral lymphocytes in vitro. Mutat Res. 2007; 626(1-2): 48-52.KayaFFTopaktasM.Genotoxic effects of potassium bromate on human peripheral lymphocytes in vitroMutat Res20076261-2485210.1016/j.mrgentox.2006.08.006Search in Google Scholar
M’Bemba-Meka P, Lemieux N, Chakrabarti SK. Role of oxidative stress and intracellular calcium in nickel carbonate hydroxide-induced sister-chromatid exchange, and alterations in replication index and mitotic index in cultured human peripheral blood lymphocytes. Arch Toxicol. 2007; 81(2): 89-99.M’Bemba-MekaPLemieuxNChakrabartiSK.Role of oxidative stress and intracellular calcium in nickel carbonate hydroxide-induced sister-chromatid exchange, and alterations in replication index and mitotic index in cultured human peripheral blood lymphocytesArch Toxicol2007812899910.1007/s00204-006-0128-7Search in Google Scholar
Rooney DE, Ed. Human Cytogenetics. A Practical Approach, 3rd ed., Vol. 2: Malignancy and Acquired Abnormalities. Oxford, UK: Oxford University Press, 2001.RooneyDEHuman Cytogenetics. A Practical Approach3rd edVol. 2Malignancy and Acquired AbnormalitiesOxford, UKOxford University Press2001Search in Google Scholar
Khabour OF, Saleh N, Alzoubi KH, Hisaindee S, Al-Fyad D, Al-Kaabi L, et al. Genotoxicity of structurally related copper and zinc containing Schiff base complexes. Drug Chem Toxicol. 2013; 36(4): 435-442.KhabourOFSalehNAlzoubiKHHisaindeeSAl-FyadDAl-KaabiLet al.Genotoxicity of structurally related copper and zinc containing Schiff base complexesDrug Chem Toxicol201336443544210.3109/01480545.2013.776577Search in Google Scholar
Ivett JL, Tice RR. Average generation time: A new method of analysis and quantitation of cellular proliferation kinetics. Environ Mutagen. 1982; 4: 358-370.IvettJLTiceRR.Average generation time: A new method of analysis and quantitation of cellular proliferation kineticsEnviron Mutagen19824358370Search in Google Scholar
Tsai KL, Chiu TH, Tsai MH, Chen HY, Ou HC. Vinorelbine-induced oxidative injury in human endothelial cells mediated by AMPK/PKC/NADPH/NF-kappaB pathways. Cell Biochem Biophys. 2012; 62(3): 467-479.TsaiKLChiuTHTsaiMHChenHYOuHC.Vinorelbine-induced oxidative injury in human endothelial cells mediated by AMPK/PKC/NADPH/NF-kappaB pathwaysCell Biochem Biophys201262346747910.1007/s12013-011-9333-ySearch in Google Scholar
Zhao J, Li H, Zhai Q, Qiu Y, Niu Y, Dai Y, et al. [Endonuclease modified comet assay for oxidative DNA damage induced by detection of genetic toxicants]. Zhonghua Yu Fang Yi Xue Za Zhi. 2014; 48(3): 208-212.ZhaoJLiHZhaiQQiuYNiuYDaiYet al.[Endonuclease modified comet assay for oxidative DNA damage induced by detection of genetic toxicants]Zhonghua Yu Fang Yi Xue Za Zhi2014483208212Search in Google Scholar
Madhu P, Reddy KP, Reddy PS. Melatonin reduces oxidative stress and restores mitochondrial function in the liver of rats exposed to chemotherapeutics. J Exp Zool A Ecol Genet Physiol. 2015; 323(5): 301-308.MadhuPReddyKPReddyPS.Melatonin reduces oxidative stress and restores mitochondrial function in the liver of rats exposed to chemotherapeuticsJ Exp Zool A Ecol Genet Physiol2015323530130810.1002/jez.1917Search in Google Scholar
Lee-Chen SF, Chen CL, Ho LY, Hsu PC, Chang JT, Sun CM, et al. Role of oxidative DNA damage in hydroxychavicol-induced genotoxicity. Mutagenesis. 1996; 11(5): 519-523.Lee-ChenSFChenCLHoLYHsuPCChangJTSunCMet al.Role of oxidative DNA damage in hydroxychavicol-induced genotoxicityMutagenesis199611551952310.1093/mutage/11.5.519Search in Google Scholar
Ogura H, Takeuchi T, Morimoto K. A comparison of the 8-hydroxydeoxyguanosine, chromosome aberrations and micronucleus techniques for the assessment of the genotoxicity of mercury compounds in human blood lymphocytes. Mutat Res. 1996; 340(2-3): 175-182.OguraHTakeuchiTMorimotoK.A comparison of the 8-hydroxydeoxyguanosine, chromosome aberrations and micronucleus techniques for the assessment of the genotoxicity of mercury compounds in human blood lymphocytesMutat Res19963402-317518210.1016/S0165-1110(96)90047-0Search in Google Scholar
Tari C, Fournier N, Briand C, Ducet G, Crevat A. Action of vinca alkaloides on calcium movements through mitochondrial membrane. Pharmacol Res Commun. 1986; 18(6): 519-528.TariCFournierNBriandCDucetGCrevatA.Action of vinca alkaloides on calcium movements through mitochondrial membranePharmacol Res Commun198618651952810.1016/0031-6989(86)90147-5Search in Google Scholar
Sanchez P, Llorente MT, Castano A. Flow cytometric detection of micronuclei and cell cycle alterations in fish-derived cells after exposure to three model genotoxic agents: Mitomycin C, vincristine sulfate and benzo(a) pyrene. Mutat Res. 2000; 465(1-2): 113-122.SanchezPLlorenteMTCastanoA.Flow cytometric detection of micronuclei and cell cycle alterations in fish-derived cells after exposure to three model genotoxic agents: Mitomycin C, vincristine sulfate and benzo(a) pyreneMutat Res20004651-211312210.1016/S1383-5718(99)00218-1Search in Google Scholar
Le Fevre AC, Boitier E, Marchandeau JP, Sarasin A, Thybaud V. Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling. Mutat Res. 2007; 619(1-2): 16-29.Le FevreACBoitierEMarchandeauJPSarasinAThybaudV.Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profilingMutat Res20076191-2162910.1016/j.mrfmmm.2006.12.007Search in Google Scholar
Geriyol P, Basavanneppa HP, Dhananjaya BL. Protecting effect of caffeine against vinblastine (an anticancer drug) induced genotoxicity in mice. Drug Chem Toxicol. 2015; 38(2): 188-195.GeriyolPBasavanneppaHPDhananjayaBL.Protecting effect of caffeine against vinblastine (an anticancer drug) induced genotoxicity in miceDrug Chem Toxicol201538218819510.3109/01480545.2014.928720Search in Google Scholar
Wang YJ, Zhang LS. [Evaluation of the genotoxicity of vincristine and colchicine using mouse lymphoma tk mutation assay]. Wei Sheng Yan Jiu. 2006; 35(2): 179-181.WangYJZhangLS.[Evaluation of the genotoxicity of vincristine and colchicine using mouse lymphoma tk mutation assay]Wei Sheng Yan Jiu2006352179181Search in Google Scholar
Choudhury RC, Das B, Misra S, Jagdale MB. Cytogenetic toxicity of vincristine. J Environ Pathol Toxicol Oncol. 2000; 19(4): 347-355.ChoudhuryRCDasBMisraSJagdaleMB.Cytogenetic toxicity of vincristineJ Environ Pathol Toxicol Oncol2000194347355Search in Google Scholar
Xing SG, Shi X, Wu ZL, Chen JK, Wallace W, Whong WZ, et al. Transplacental genotoxicity of triethyl-enemelamine, benzene, and vinblastine in mice. Teratog Carcinog Mutagen. 1992; 12(5): 223-230.XingSGShiXWuZLChenJKWallaceWWhongWZet al.Transplacental genotoxicity of triethyl-enemelamine, benzene, and vinblastine in miceTeratog Carcinog Mutagen199212522323010.1002/tcm.1770120505Search in Google Scholar
Novichkova EA, Onishchenko GE, Shtil AA. Microtubule depolymerization by vincristine causes cell death after transition from C mitosis to interphase. Dokl Biol Sci. 2003; 393: 575-578.NovichkovaEAOnishchenkoGEShtilAA.Microtubule depolymerization by vincristine causes cell death after transition from C mitosis to interphaseDokl Biol Sci200339357557810.1023/B:DOBS.0000010328.92771.95Search in Google Scholar
Horton JK, Houghton PJ, Houghton JA. Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenografts. Biochem Pharmacol. 1988; 37(20): 3995-4000.HortonJKHoughtonPJHoughtonJA.Relationships between tumor responsiveness, vincristine pharmacokinetics and arrest of mitosis in human tumor xenograftsBiochem Pharmacol198837203995400010.1016/0006-2952(88)90085-8Search in Google Scholar
